First rituximab administration caused significant reduction in the concentration of interstitial collagenase (MMP-1) in serum of RA patients (p < 0.01) as evaluated on week 2, prior to the next drug infusion (Fig. 1, Figure 1S). The gene discussed is MMP1; the disease is rheumatoid arthritis.